Senior scientist- Process development drug product at CureVac AG - Boston, MA, US
Scientist Early Process Development
Contact Michael Thommen
Scientist
Contact Markus Hirsch
Animal welfare officer
Contact Brigitte Schulz-Klaus
Prozessingenieur
Contact Danny Schiprowski
Coordinator GMP Production
Contact Christoph Povel
Clinical Trial Manager
Contact Julia Kerpes
Vice President Global Procurement
Contact Patrice Lemonnier
CureVac is a biopharmaceutical company that develops and commercializes mRNA-based therapies for the treatment of cancer and infectious diseases.